Battling cancer: How OncoPrecision is using AI to change the game

After raising $4.2m in pre-seed and seed funding, the Argentina-based biotech start-up is aiming to offer its diagnostics services to cancer clinics by the end of 2023.

ByDavid Bogoslaw

30 October 2022•8 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Latin America North America US AI Life Sciences

Battling cancer: How OncoPrecision is using AI to change the game

GRIDX

SOSV

Related articles